EP Patent

EP1581260B1 — Polymeric reagents comprising a ketone or a related functional group

Assigned to Nektar Therapeutics · Expires 2014-09-17 · 12y expired

What this patent protects

Patent listed against naloxegol-oxalate.

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: EP1581260B1
Jurisdiction: EP
Classification: —
Expires: 2014-09-17
Drug substance claim: No
Drug product claim: No
Assignee: Nektar Therapeutics
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.